Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age with Iron Deficiency Anemia

Recruiting

Phase 3

Ferric DerisomaltoseMulti-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age with Iron Deficiency Anemia

Sponsor:

Pharmacosmos A/S

Code:

NCT05179226

Conditions

Iron Deficiency, Anaemia in Children

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Interventions

Ferric Derisomaltose

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Pharmacosmos A/S on 2025-02-24.